MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$3,672K
Unit: Thousand (K) dollars

Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
0 25 80* -
Research and development
1,345 1,297 1,315* 1,203
Impairment of intangible assets
--0* 0
General and administrative
1,326 1,416 1,393* 1,315
Total operating expenses
2,671 2,713 2,708* 2,518
Loss from operations
-2,671 -2,688 -2,628* -2,518
Interest income
217 163 165* 187
Interest expense
719 229 82* 57
Foreign exchange losss (gaines)
-104 4 -997* -418
Change in fair value of derivative and warrant liabilities
128 0 -1* 0
Total other income (expense), net
-734 -62 -913* -288
Loss before income tax expense (benefit)
---3,542* -2,806
Income tax expense (benefit)
--0* 0
Net loss
-3,405 -2,800 -3,542* -2,806
Gain on extinguishment of series a convertible preferred stock-Series AConvertible Preferred Stock
---0
Deemed dividends on preferred stock-Series APreferred Stock
--0* 0
Deemed dividends on preferred stock-Redeemable Series AConvertible Preferred Stock
--0* -
Deemed dividend on preferred stock-Series AConvertible Preferred Stock
---0
Gain on extinguishment of series a preferred stock-Series APreferred Stock
--0* -
Change in cumulative translation adjustment
-267 -100 --
Net loss attributable to common stockholders
---3,542 -2,806
Total comprehensive loss
-3,672 -2,808 --
Basic EPS
-0.21 -0.17 -0.276 -0.19
Basic Average Shares
15,910,724 15,968,591 12,853,705 14,739,800
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Total comprehensiveloss-$3,672K Net loss-$3,405K (-46.77%↓ Y/Y)Change in cumulativetranslation adjustment-$267K Loss from operations-$2,671K (35.37%↑ Y/Y)Total other income(expense), net-$734K (-140.49%↓ Y/Y)Interest income$217K (-8.44%↓ Y/Y)Total operatingexpenses$2,671K (-35.37%↓ Y/Y)Interest expense$719K (5891.67%↑ Y/Y)Change in fair value ofderivative and warrant...$128K Foreign exchange losss(gaines)-$104K (-106.55%↓ Y/Y)Research and development$1,345K (-42.05%↓ Y/Y)General andadministrative$1,326K (-26.82%↓ Y/Y)

Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics, Inc. (ALLR)